Trials / Terminated
TerminatedNCT02837783
A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this trial is to determine the effect of linaclotide on abdominal girth in IBS-C participants with the baseline symptoms of abdominal bloating and an increased abdominal girth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linaclotide | Oral, once daily |
| DRUG | Placebo | Oral, one daily |
Timeline
- Start date
- 2016-12-21
- Primary completion
- 2018-10-31
- Completion
- 2018-10-31
- First posted
- 2016-07-20
- Last updated
- 2021-12-06
- Results posted
- 2021-12-06
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02837783. Inclusion in this directory is not an endorsement.